News and Breakthroughs

A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.

On Friday, May 13, 2022, the Translational Research in Solid Tumors (TRIST) Program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University hosted the TRIST Symposium on the Chicago campus of Northwestern University. The focus of the program is "Drug Development from Bench to Bedside".

A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.

Lurie Cancer Center has named Marquita Lewis-Thames, PhD; June McKoy, MD, MPH, JD, MBA; Jonathan Moreira, MD; and Adam B. Murphy, MD, MBA, MSCI, to new leadership roles within the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. 

After he was diagnosed with kidney cancer at the age of 34, Jon Resnick and his wife, Amy, signed up for their first Cancer Survivors’ Celebration Walk & 5K. Together with daughters Lindsey and Jordyn, they haven’t missed a year supporting Jon and celebrating as a family since 2003! Lindsey and Jordyn, who first joined our event in strollers, now travel from wherever they are. “It’s a priority,” says Amy. “We have to be here every year.”

To Judith Mayzel, philanthropy at Northwestern University Feinberg School of Medicine is all about community: donors, scientists, physicians, and trainees all working together to make the world a better place.

Investigators discovered that decreased expression of the G alpha 13 protein in mice and human pancreatic tumors promotes tumor growth, according to recent findings.

Nine members of the Lurie Cancer Center are among the “world’s most influential scientific minds,” according to the Highly Cited Researchers (HCR) list released by Clarivate Analytics, part of the Web of Science Group. The list recognizes “true pioneers in their fields over the last decade,” demonstrated by the publication of multiple papers that rank in the top 1% of scholarly publication cited by their peers.

A well-established cancer cell transcription factor and its newly identified co-factor work together to drive cancer cell proliferation, according to a Northwestern Medicine study published in Science Advances.

Last fall a string of fortuitous connections led to a special gift from one of the medical school’s legendary donors to help equalize healthcare for Black women in Chicago.

Black women with early hormone receptor-positive breast cancer experienced shorter relapse-free intervals and overall survival compared with white women, according to findings published in JAMA Oncology.

Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.

Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.

A novel combination treatment approach extended survival in mice with pancreatic cancer, demonstrating a potential second-line therapy for patients.

A genetic mutation changing just one base pair of nucleotides greatly increases risk of a lethal subtype of childhood acute lymphoblastic leukemia, according to a recent study.